#ASPChat Transcript
Healthcare social media transcript of the #ASPChat hashtag.
β ().
See #ASPChat Influencers/Analytics.
| Profile | Tweet |
|---|---|
 | #ASPchat @ASP_Chat Q1 follow-up. Did you know that πΎππΌ MRSA nares swabs have excellent negative predictive value for MRSA pneumonia? They can be a great tool for dropping that empiric vancomycin! #ASPchat More: https://t.co/bXyJgvRn29 |
 | Bug Pharmacist π𧫠Tim Gauthier @IDstewardship RT @ASP_Chat: Q1. Do you π€ remember any of the first clinical pearls you learned as a new practitioner? What was it/ were they? #ASPchat https://t.co/IRym7dezKm |
| Bug Pharmacist π𧫠Tim Gauthier @IDstewardship RT @ASP_Chat: Q1 follow-up. Did you know that πΎππΌ MRSA nares swabs have excellent negative predictive value for MRSA pneumonia? They can be a great tool for dropping that empiric vancomycin! #ASPchat More: https://t.co/bXyJgvRn29 |
 | Mary Douglass Smith @SC_Pharmacist RT @ASP_Chat: Q1. Do you π€ remember any of the first clinical pearls you learned as a new practitioner? What was it/ were they? #ASPchat https://t.co/IRym7dezKm |
| Bug Pharmacist π𧫠Tim Gauthier @IDstewardship RT @bergmanscott: 1st Pearl is that #ASPchat can help lots! |
 | Muhammad Effendi @FND_pharmacy π¨Ready. Set. #ASPChat !!! π¨ |
| Bug Pharmacist π𧫠Tim Gauthier @IDstewardship @ASP_Chat A1. Ertapenem is monkey-cillin, lacks βAPEβ coverage. #ASPchat https://t.co/yRXHLHb4Lc |
 | Daniel MuΓ±oz, BCCCP @dfmunozp @olivaresabara @idelama otra herramienta para acabar con el uso inadecuado de vancomicina |
 | Brad Langford @BRxAD @ASP_Chat One of the earliest clinical pearls is never to use rifampin alone due to the rapid development of resistance. I also learned to be careful when reporting rifampin on culture and susceptibility results, or it will get used alone! https://t.co/BZflGlvyU4 #ASPChat |
| Brad Langford @BRxAD RT @ASP_Chat: Q1 follow-up. Did you know that πΎππΌ MRSA nares swabs have excellent negative predictive value for MRSA pneumonia? They can be a great tool for dropping that empiric vancomycin! #ASPchat More: https://t.co/bXyJgvRn29 |
| Bug Pharmacist π𧫠Tim Gauthier @IDstewardship RT @BRxAD: @ASP_Chat One of the earliest clinical pearls is never to use rifampin alone due to the rapid development of resistance. I also learned to be careful when reporting rifampin on culture and susceptibility results, or it will get used alone! https://t.co/BZflGlvyU4 #ASPChat |
| Bug Pharmacist π𧫠Tim Gauthier @IDstewardship @BRxAD @ASP_Chat Yes! This was an early one for me too. Still comes up all the time. Very important, not monotherapy rifampin!! #ASPchat |
| Muhammad Effendi @FND_pharmacy @ASP_Chat Love this practice changing education for providers who are not already aware of utility of MRSA screen. Tell hesitant providers that we would deescalate even for febrile neutropenic patients with negative MRSA swab ! @Day_Mac3 #ASPchat #PharmCritChats |
| Muhammad Effendi @FND_pharmacy @ASP_Chat @Day_Mac3 https://t.co/h7VPzW6bu0 #ASPchat #PharmCritChats |
| Brad Langford @BRxAD @IDstewardship @ASP_Chat Showing my age.. but the spectrum of activity mnemonics I learned: Amoxicillin - HiPEEL (H flu, Proteus, E coli, E faecalis Listeria) 1st Gen Cephalosporins - PEcK (Proteus Ecoli Klebsiella) Thanks to rising resistance, these pearls are not shiny any more. #ASPChat |
| #ASPchat @ASP_Chat Q2. Which clinical pearl is amongst the first you teach to new students, fellows, or residents? #ASPchat https://t.co/KLWnFjZH16 |
| Bug Pharmacist π𧫠Tim Gauthier @IDstewardship RT @ASP_Chat: Q2. Which clinical pearl is amongst the first you teach to new students, fellows, or residents? #ASPchat https://t.co/KLWnFjZH16 |
| Bug Pharmacist π𧫠Tim Gauthier @IDstewardship RT @BRxAD: @IDstewardship @ASP_Chat Showing my age.. but the spectrum of activity mnemonics I learned: Amoxicillin - HiPEEL (H flu, Proteus, E coli, E faecalis Listeria) 1st Gen Cephalosporins - PEcK (Proteus Ecoli Klebsiella) Thanks to rising resistance, these pearls are not shiny any more. #ASPChat |
 | Critical Care Pharmacy @PharmacyCCEd π¨Excited to collaborate with @ASP_Chat ! Be sure to join the discussion! Ready. Set. #ASPChat ! π¨ |
| Bug Pharmacist π𧫠Tim Gauthier @IDstewardship @ASP_Chat A2. Dont touch anything. C diff likes to live in the cracks of arm chairs and in bed rails. Infection control is important! #ASPchat |
 | Rxtepen π @Rxtepen RT @PharmacyCCEd: π¨Excited to collaborate with @ASP_Chat ! Be sure to join the discussion! Ready. Set. #ASPChat ! π¨ |
 | Rodney E. Rohde, PhD "Doc R" @RodneyRohde RT @ASP_Chat: π Welcome to the #ASPchat co-hosted with @PharmacyCCEd on abx stewardship and clinical pearls!!! We will be using a thread format for this chat. ****** Only rule: Use #ASPchat in all tweets and replies ****** https://t.co/vi5XgkNuJn |
| #ASPchat @ASP_Chat Q2 Follow-Up. Did you know that ππ dual beta-lactam therapy is rarely indicated? #ASPchat Some exceptions are here: https://t.co/S00dAosQ2R #ASPchat |
| Muhammad Effendi @FND_pharmacy @ASP_Chat So many to choose from!Iβll pick one common one that came up today...βciprofloxacin doesnβt penetrate the lungs because itβs not a respiratory FQβ. Hopefully we are staying away from FQ when possible but if needed cipro penetrates fine! Poor strep coverage =not resp FQ #ASPChat |
| Bug Pharmacist π𧫠Tim Gauthier @IDstewardship RT @FND_pharmacy: @ASP_Chat So many to choose from!Iβll pick one common one that came up today...βciprofloxacin doesnβt penetrate the lungs because itβs not a respiratory FQβ. Hopefully we are staying away from FQ when possible but if needed cipro penetrates fine! Poor strep coverage =not resp FQ #ASPChat |
| Rodney E. Rohde, PhD "Doc R" @RodneyRohde RT @IDstewardship: @ASP_Chat A2. Dont touch anything. C diff likes to live in the cracks of arm chairs and in bed rails. Infection control is important! #ASPchat |
| Brad Langford @BRxAD @ASP_Chat I find many struggle with this.. so I like the pearl regarding SPin and SNout. SP = SPecificity (test Positive) --> Rules IN a disease SN = SeNsitivity (test Negative) --> Rules OUT a disease #ASPChat @jackcfchong https://t.co/d6xApGpv2a |
| Muhammad Effendi @FND_pharmacy @ASP_Chat Being in the ICU, dosing of antibiotics in critically ill is something that comes up quickly. Renal dose adjustment section in Lexicomp was not made for this patient population. In absence of TDM, I base dosing off of U/O, severity of infection, weight, source, and more #ASPchat |
| #ASPchat @ASP_Chat Q3. What is one clinical pearl you learned when attending a π©βπ«π¨βπ« scientific meeting? Who taught it to you (if you recall)? #ASPchat |
| Muhammad Effendi @FND_pharmacy @ASP_Chat High risk cdiff drugs ! Fun fact - before being termed clostridium difficult , cdiff was often called βclindamycin colitisβ ! #ASPchat |
| Muhammad Effendi @FND_pharmacy RT @ASP_Chat: π Welcome to the #ASPchat co-hosted with @PharmacyCCEd on abx stewardship and clinical pearls!!! We will be using a thread format for this chat. ****** Only rule: Use #ASPchat in all tweets and replies ****** https://t.co/vi5XgkNuJn |
| #ASPchat @ASP_Chat Q3 Follow-Up. Did you know that the ending of hepatitis C drugs indicates their mechanism of action / class? https://t.co/SY7gUSUxE3 #ASPchat pic from @ACCP 2016 meeting ππΌ #ASPchat https://t.co/SgcJT28zA8 |
 | nao @nao_01_ RT @BRxAD: @ASP_Chat One of the earliest clinical pearls is never to use rifampin alone due to the rapid development of resistance. I also learned to be careful when reporting rifampin on culture and susceptibility results, or it will get used alone! https://t.co/BZflGlvyU4 #ASPChat |
| #ASPchat @ASP_Chat Q3 Follow-Up 2. Do you know that many new and expected antibioitics lack π¦ MDR Acinetobacter activity? #ASPchat Here is a pic from the @SHEA_Epi 2019 meeting https://t.co/rVDXVhjFEa via @mmPharmD https://t.co/DhYVBhchv8 |
| Rodney E. Rohde, PhD "Doc R" @RodneyRohde RT @ASP_Chat: Q3. What is one clinical pearl you learned when attending a π©βπ«π¨βπ« scientific meeting? Who taught it to you (if you recall)? #ASPchat |
| Rodney E. Rohde, PhD "Doc R" @RodneyRohde RT @ASP_Chat: Q3 Follow-Up. Did you know that the ending of hepatitis C drugs indicates their mechanism of action / class? https://t.co/SY7gUSUxE3 #ASPchat pic from @ACCP 2016 meeting ππΌ #ASPchat https://t.co/SgcJT28zA8 |
| Brad Langford @BRxAD @ASP_Chat Limiting the use of the "4Cs" can reduce the incidence of #CDI: -ciprofloxacin (and other fluoroquinolones) -clindamycin -co-amoxiclav -cephalosporins (particularly 3rd generation) https://t.co/rFtxOnQgQF [although most antibiotics are risky, these are the worst] #ASPChat |
| Muhammad Effendi @FND_pharmacy RT @ASP_Chat: Q1. Do you π€ remember any of the first clinical pearls you learned as a new practitioner? What was it/ were they? #ASPchat https://t.co/IRym7dezKm |
| Muhammad Effendi @FND_pharmacy RT @ASP_Chat: Q1 follow-up. Did you know that πΎππΌ MRSA nares swabs have excellent negative predictive value for MRSA pneumonia? They can be a great tool for dropping that empiric vancomycin! #ASPchat More: https://t.co/bXyJgvRn29 |
| Muhammad Effendi @FND_pharmacy RT @ASP_Chat: Q2. Which clinical pearl is amongst the first you teach to new students, fellows, or residents? #ASPchat https://t.co/KLWnFjZH16 |
| Rodney E. Rohde, PhD "Doc R" @RodneyRohde RT @ASP_Chat: Q2 Follow-Up. Did you know that ππ dual beta-lactam therapy is rarely indicated? #ASPchat Some exceptions are here: https://t.co/S00dAosQ2R #ASPchat |
 | ΨΉΨ¨Ψ―Ψ§ΩΨ±ΨΩ
Ω Ψ§ΩΨ³ΩΩΨΉΨ―Ω @ph_a_swaidi RT @BRxAD: @ASP_Chat Limiting the use of the "4Cs" can reduce the incidence of #CDI: -ciprofloxacin (and other fluoroquinolones) -clindamycin -co-amoxiclav -cephalosporins (particularly 3rd generation) https://t.co/rFtxOnQgQF [although most antibiotics are risky, these are the worst] #ASPChat |
| Critical Care Pharmacy @PharmacyCCEd RT @ASP_Chat: Q1. Do you π€ remember any of the first clinical pearls you learned as a new practitioner? What was it/ were they? #ASPchat https://t.co/IRym7dezKm |
 | Wilbert J Fuerte PharmD, BCIDP @FuerteWilbert One of the most powerful tools of a successful ASP and yet so underutilized... monthly collaborative meeting with prescribers within your institution #ASPchat https://t.co/hU2Tq5W5yM |
| Critical Care Pharmacy @PharmacyCCEd RT @ASP_Chat: Q1 follow-up. Did you know that πΎππΌ MRSA nares swabs have excellent negative predictive value for MRSA pneumonia? They can be a great tool for dropping that empiric vancomycin! #ASPchat More: https://t.co/bXyJgvRn29 |
| Daniel MuΓ±oz, BCCCP @dfmunozp @olivaresabara @idelama Lo que siempre repito. Cipro excelente llegada a pulmΓ³n, igual o mejor que levo. No se βreconoceβ como FQ respiratoria por elevada R a pneumococo en gringolandia. |
| Critical Care Pharmacy @PharmacyCCEd RT @ASP_Chat: Q2. Which clinical pearl is amongst the first you teach to new students, fellows, or residents? #ASPchat https://t.co/KLWnFjZH16 |
| Critical Care Pharmacy @PharmacyCCEd RT @ASP_Chat: Q2 Follow-Up. Did you know that ππ dual beta-lactam therapy is rarely indicated? #ASPchat Some exceptions are here: https://t.co/S00dAosQ2R #ASPchat |
| Critical Care Pharmacy @PharmacyCCEd RT @ASP_Chat: Q3. What is one clinical pearl you learned when attending a π©βπ«π¨βπ« scientific meeting? Who taught it to you (if you recall)? #ASPchat |
 | Kaitlin Landolf @KaitlinLandolf RT @ASP_Chat: Q2 Follow-Up. Did you know that ππ dual beta-lactam therapy is rarely indicated? #ASPchat Some exceptions are here: https://t.co/S00dAosQ2R #ASPchat |
| #ASPchat @ASP_Chat Q3 Follow-Up 3. Have you met π€ Dr. Plasma to help with empirical antimicrobial section? https://t.co/aeQjDUvnyx via @IDSAInfo 2018 from @julie_justo #ASPchat https://t.co/C3NcRCdMNx |
| #ASPchat @ASP_Chat Q4. What is your π€© favorite clinical pearl about antimicrobial use in critical care? #ASPchat ...maybe pull from your favorite interventions to make? https://t.co/fFGloIohJy |
 | Chris Bland @blandman19 RT @ASP_Chat: Q3 Follow-Up 3. Have you met π€ Dr. Plasma to help with empirical antimicrobial section? https://t.co/aeQjDUvnyx via @IDSAInfo 2018 from @julie_justo #ASPchat https://t.co/C3NcRCdMNx |
| Brad Langford @BRxAD RT @ASP_Chat: Q3 Follow-Up 3. Have you met π€ Dr. Plasma to help with empirical antimicrobial section? https://t.co/aeQjDUvnyx via @IDSAInfo 2018 from @julie_justo #ASPchat https://t.co/C3NcRCdMNx |
| Bug Pharmacist π𧫠Tim Gauthier @IDstewardship RT @ASP_Chat: Q3 Follow-Up 3. Have you met π€ Dr. Plasma to help with empirical antimicrobial section? https://t.co/aeQjDUvnyx via @IDSAInfo 2018 from @julie_justo #ASPchat https://t.co/C3NcRCdMNx |
| Bug Pharmacist π𧫠Tim Gauthier @IDstewardship RT @ASP_Chat: Q4. What is your π€© favorite clinical pearl about antimicrobial use in critical care? #ASPchat ...maybe pull from your favorite interventions to make? https://t.co/fFGloIohJy |
| Bug Pharmacist π𧫠Tim Gauthier @IDstewardship RT @FuerteWilbert: One of the most powerful tools of a successful ASP and yet so underutilized... monthly collaborative meeting with prescribers within your institution #ASPchat https://t.co/hU2Tq5W5yM |
| Bug Pharmacist π𧫠Tim Gauthier @IDstewardship RT @BRxAD: @ASP_Chat Limiting the use of the "4Cs" can reduce the incidence of #CDI: -ciprofloxacin (and other fluoroquinolones) -clindamycin -co-amoxiclav -cephalosporins (particularly 3rd generation) https://t.co/rFtxOnQgQF [although most antibiotics are risky, these are the worst] #ASPChat |
| Bug Pharmacist π𧫠Tim Gauthier @IDstewardship RT @ASP_Chat: Q3 Follow-Up 2. Do you know that many new and expected antibioitics lack π¦ MDR Acinetobacter activity? #ASPchat Here is a pic from the @SHEA_Epi 2019 meeting https://t.co/rVDXVhjFEa via @mmPharmD https://t.co/DhYVBhchv8 |
| Bug Pharmacist π𧫠Tim Gauthier @IDstewardship RT @ASP_Chat: Q3 Follow-Up. Did you know that the ending of hepatitis C drugs indicates their mechanism of action / class? https://t.co/SY7gUSUxE3 #ASPchat pic from @ACCP 2016 meeting ππΌ #ASPchat https://t.co/SgcJT28zA8 |
| Bug Pharmacist π𧫠Tim Gauthier @IDstewardship RT @FND_pharmacy: @ASP_Chat High risk cdiff drugs ! Fun fact - before being termed clostridium difficult , cdiff was often called βclindamycin colitisβ ! #ASPchat |
| Bug Pharmacist π𧫠Tim Gauthier @IDstewardship @FND_pharmacy @ASP_Chat Neat! #ASPchat |
| Bug Pharmacist π𧫠Tim Gauthier @IDstewardship RT @ASP_Chat: Q3. What is one clinical pearl you learned when attending a π©βπ«π¨βπ« scientific meeting? Who taught it to you (if you recall)? #ASPchat |
| Wilbert J Fuerte PharmD, BCIDP @FuerteWilbert The movement against antimicrobial resistance continues in Miami #ASPchat https://t.co/uaSF5FH2Rh |
| Bug Pharmacist π𧫠Tim Gauthier @IDstewardship @ASP_Chat A3. @BradSpellberg talked about how cidal isnβt that big of a deal many years ago at I think it was ICAAC. #ASPchat |
| Bug Pharmacist π𧫠Tim Gauthier @IDstewardship RT @FND_pharmacy: @ASP_Chat Being in the ICU, dosing of antibiotics in critically ill is something that comes up quickly. Renal dose adjustment section in Lexicomp was not made for this patient population. In absence of TDM, I base dosing off of U/O, severity of infection, weight, source, and more #ASPchat |
| Bug Pharmacist π𧫠Tim Gauthier @IDstewardship RT @BRxAD: @ASP_Chat I find many struggle with this.. so I like the pearl regarding SPin and SNout. SP = SPecificity (test Positive) --> Rules IN a disease SN = SeNsitivity (test Negative) --> Rules OUT a disease #ASPChat @jackcfchong https://t.co/d6xApGpv2a |
| Wilbert J Fuerte PharmD, BCIDP @FuerteWilbert Everyone plays a role in the movement against antimicrobial resistance #ASPchat https://t.co/RBaekYOQCJ |
| Bug Pharmacist π𧫠Tim Gauthier @IDstewardship @BRxAD @ASP_Chat @jackcfchong That is a good one! I think @OncIDPharmd or @TimbrookTT was tweeting about this not long ago, was it one of you? #ASPchat |
| Bug Pharmacist π𧫠Tim Gauthier @IDstewardship RT @ASP_Chat: Q2 Follow-Up. Did you know that ππ dual beta-lactam therapy is rarely indicated? #ASPchat Some exceptions are here: https://t.co/S00dAosQ2R #ASPchat |
| Brad Langford @BRxAD @ASP_Chat @IDSAInfo @julie_justo @blandman19 @BBookstaver_USC @KisgenUF @ACCP @IDWeek2019 @MK_IDpharm @ABXPharmD Cool list for teaching! I would add one item - "Collateral Damage" or "Second-hand Effects" to remind about impact of antibiotic use on the patient and the population ππ©βπ©βπ§βπ¦ #ASPChat |
| Bug Pharmacist π𧫠Tim Gauthier @IDstewardship @ASP_Chat A4. Meropenem will give you Listeria coverage so no need to add ampicillin to it for empiric π§ meningitis coverage. #ASPchat |
| #ASPchat @ASP_Chat Q5. What are some clinical pearls about critical care that you have learned from people outside of your profession? #ASPchat https://t.co/rrpznFtUde |
| Brad Langford @BRxAD @ASP_Chat Really applies anywhere... but "Shorter is Better" https://t.co/wqVVlQNaps c/o @BradSpellberg Rarely a need for antibiotic duration of therapy beyond 7 days for most acute non-deep seated infections #ASPChat |
| Bug Pharmacist π𧫠Tim Gauthier @IDstewardship RT @BRxAD: @ASP_Chat Really applies anywhere... but "Shorter is Better" https://t.co/wqVVlQNaps c/o @BradSpellberg Rarely a need for antibiotic duration of therapy beyond 7 days for most acute non-deep seated infections #ASPChat |
| Bug Pharmacist π𧫠Tim Gauthier @IDstewardship @BRxAD @ASP_Chat @BradSpellberg Love that shorter is better pub. Was promoting it today!!! (Like most days) #ASPchat |
| Bug Pharmacist π𧫠Tim Gauthier @IDstewardship RT @ASP_Chat: Q5. What are some clinical pearls about critical care that you have learned from people outside of your profession? #ASPchat https://t.co/rrpznFtUde |
| Bug Pharmacist π𧫠Tim Gauthier @IDstewardship @ASP_Chat A5. A nurse taught me about how classical music can help ICU patients during their care. I thought that was pretty neat. #ASPchat |
| Wilbert J Fuerte PharmD, BCIDP @FuerteWilbert Interestingly SSIs rate has decreased since the introduction of the movement #ASPchat https://t.co/KPZBBXuAbe |
| Brad Langford @BRxAD @ASP_Chat This collection of clinical ID pearls from @gompfsidpearls is pretty neat: https://t.co/S8N06epHbY #ASPChat |
| Daniel MuΓ±oz, BCCCP @dfmunozp @IDstewardship @ASP_Chat #ASPchat not-Vancomycin Antimicrobial therapy if 48-72h negative cultures or absence of gram positive bacteria π¦ . Plz de-escalation πͺπͺπͺ |
| Bug Pharmacist π𧫠Tim Gauthier @IDstewardship @ASP_Chat A5. Things MDs have taught me are too numerous to list. Hey me thing they have taught me: LISTEN TO THE NURSES! Nurses know what is up. (not that I didnβt listen, just they press the importance of it) #ASPchat |
 | Infectious Diseases @WSPID #ASPchat #PedsID |
| Infectious Diseases @WSPID #ASPchat #PedsdICU #PedsID |
| Chris Bland @blandman19 Teaching this skill on Monday!! I would add previous culture history which goes hand in hand with previous ABX. #ASPChat |
| Bug Pharmacist π𧫠Tim Gauthier @IDstewardship @ASP_Chat A5. Infection control taught me about proper donning/doffing of my PPE... and itβs fun that this thing exists as a neat teaching prop... #ASPchat https://t.co/uPGj2Ga6fH |
| Bug Pharmacist π𧫠Tim Gauthier @IDstewardship RT @blandman19: Teaching this skill on Monday!! I would add previous culture history which goes hand in hand with previous ABX. #ASPChat |
| Bug Pharmacist π𧫠Tim Gauthier @IDstewardship RT @dfmunozp: @IDstewardship @ASP_Chat #ASPchat not-Vancomycin Antimicrobial therapy if 48-72h negative cultures or absence of gram positive bacteria π¦ . Plz de-escalation πͺπͺπͺ |
| Bug Pharmacist π𧫠Tim Gauthier @IDstewardship RT @BRxAD: @ASP_Chat This collection of clinical ID pearls from @gompfsidpearls is pretty neat: @ASP_Chat This collection of clinical ID pearls from @gompfsidpearls is pretty neat: https://t.co/S8N06epHbY #ASPChat |
| Bug Pharmacist π𧫠Tim Gauthier @IDstewardship RT @FuerteWilbert: Interestingly SSIs rate has decreased since the introduction of the movement #ASPchat https://t.co/KPZBBXuAbe |
| Muhammad Effendi @FND_pharmacy #PharmCritChats assemble !!! @DrDrayMBA @HeavnerPharmD @hockeypharmd @lemieuxVUDINE @KAlexander4218 @PharmDuprey @Rxdoni @karenccrx @tigernole13 @Mahmoudtweets @AbdallaTweet |
 | Veronica Zafonte @VBZafonte RT @ASP_Chat: Q2 Follow-Up. Did you know that ππ dual beta-lactam therapy is rarely indicated? #ASPchat Some exceptions are here: https://t.co/S00dAosQ2R #ASPchat |
| Daniel MuΓ±oz, BCCCP @dfmunozp RT @IDstewardship: @ASP_Chat A5. Infection control taught me about proper donning/doffing of my PPE... and itβs fun that this thing exists as a neat teaching prop... #ASPchat https://t.co/uPGj2Ga6fH |
| #ASPchat @ASP_Chat Q6. Clinical pearl free for all!!! (If you have held it in this long)... share a clinical pearl, doesn't have to be related to antimicrobials. We want to ππΌ hear it! #ASPchat https://t.co/PGw76lhL7B |
| Kaitlin Landolf @KaitlinLandolf @IDstewardship @BRxAD @ASP_Chat @BradSpellberg This is great! During my surgical ICU rotations I always find myself promoting the STOP-IT trial #stopit #aspchat https://t.co/neo7yjiIAb |
| Brad Langford @BRxAD @ASP_Chat That reported as "bilateral cellulitis" is rarely cellulitis #ASPChat #stasisdermatitis |
 | SΓ©bastien Poulin @sebpoule RT @BRxAD: @ASP_Chat That reported as "bilateral cellulitis" is rarely cellulitis #ASPChat #stasisdermatitis |
 | Robert Crawford @RC3_IDPharmD RT @ASP_Chat: Q3 Follow-Up 3. Have you met π€ Dr. Plasma to help with empirical antimicrobial section? https://t.co/aeQjDUvnyx via @IDSAInfo 2018 from @julie_justo #ASPchat https://t.co/C3NcRCdMNx |
| Wilbert J Fuerte PharmD, BCIDP @FuerteWilbert Pop Quiz !!! Over 23,000 people die every year in the US alone as a consequence of antimicrobial resistance. Can you estimate how many pets die for the same reason? #ASPchat https://t.co/Xukkx3lKGM |
| Brad Langford @BRxAD @ASP_Chat What does everyone think of...? for anaerobic coverage -above diaphragm: clindamycin (or penicillin) -below diaphragm: metronidazole Perhaps too simplistic? #ASPChat |
| #ASPchat @ASP_Chat Q6 Follow-up. βπΌ Replace magnesium first! #ASPchat https://t.co/jQ235YqvJa |
| Infectious Diseases @WSPID #nurses play a crucial role in healthcare services both in HIC and LMICs. A multidisciplinary approach in healthcare is key. Also multispeciality collaboration #PedsID #pediatricians #PedsICU |
| Bug Pharmacist π𧫠Tim Gauthier @IDstewardship RT @ASP_Chat: Q6 Follow-up. βπΌ Replace magnesium first! #ASPchat https://t.co/jQ235YqvJa |
| Bug Pharmacist π𧫠Tim Gauthier @IDstewardship @BRxAD @ASP_Chat I was taught this too. I think itβs fine for introductory learning. #ASPchat |
| Bug Pharmacist π𧫠Tim Gauthier @IDstewardship RT @BRxAD: @ASP_Chat That reported as "bilateral cellulitis" is rarely cellulitis #ASPChat #stasisdermatitis |
| Bug Pharmacist π𧫠Tim Gauthier @IDstewardship RT @KaitlinLandolf: @IDstewardship @BRxAD @ASP_Chat @BradSpellberg This is great! During my surgical ICU rotations I always find myself promoting the STOP-IT trial #stopit #aspchat https://t.co/neo7yjiIAb |
| Bug Pharmacist π𧫠Tim Gauthier @IDstewardship @KaitlinLandolf @BRxAD @ASP_Chat @BradSpellberg I know @SICUPharmD likes that one too!!! #ASPchat |
| Muhammad Effendi @FND_pharmacy @ASP_Chat If I see voriconazole my eyes light up! Drug interaction city. One of the most potent ones with a commonly used med definitely voriconazole + midazolam. X4 increase in t1/2 and x3 AUC and Cmax increase ! #ASPChat https://t.co/CHKC5pUOB4 |
| #ASPchat @ASP_Chat π Thank you for joining this #ASPchat! We are so thrilled to be able to connect with @PharmacyCCed for this chat and hope to have many more collaborations to come! π π See you next month, watch your Twitter and the IDstewardship monthly newsletter for what is next!!! |
| Bug Pharmacist π𧫠Tim Gauthier @IDstewardship RT @ASP_Chat: π Thank you for joining this #ASPchat! We are so thrilled to be able to connect with @PharmacyCCed for this chat and hope to have many more collaborations to come! π π See you next month, watch your Twitter and the IDstewardship monthly newsletter for what is next!!! |
| Bug Pharmacist π𧫠Tim Gauthier @IDstewardship RT @FND_pharmacy: @ASP_Chat If I see voriconazole my eyes light up! Drug interaction city. One of the most potent ones with a commonly used med definitely voriconazole + midazolam. X4 increase in t1/2 and x3 AUC and Cmax increase ! #ASPChat https://t.co/CHKC5pUOB4 |
 | Tony Gerlach @SICUPharmD RT @IDstewardship: @KaitlinLandolf @BRxAD @ASP_Chat @BradSpellberg I know @SICUPharmD likes that one too!!! #ASPchat |
| Tony Gerlach @SICUPharmD RT @ASP_Chat: Q4. What is your π€© favorite clinical pearl about antimicrobial use in critical care? #ASPchat ...maybe pull from your favorite interventions to make? https://t.co/fFGloIohJy |
 | SHEA @SHEA_Epi RT @ASP_Chat: Q1. Do you π€ remember any of the first clinical pearls you learned as a new practitioner? What was it/ were they? #ASPchat https://t.co/IRym7dezKm |
| Bug Pharmacist π𧫠Tim Gauthier @IDstewardship RT @WSPID: #nurses play a crucial role in healthcare services both in HIC and LMICs. A multidisciplinary approach in healthcare is key. Also multispeciality collaboration #PedsID #pediatricians #PedsICU |
 | Jamie Kisgen @KisgenUF @BRxAD @ASP_Chat Agreed, still use this approach with new learners. #ASPchat |
| SHEA @SHEA_Epi RT @ASP_Chat: Q1 follow-up. Did you know that πΎππΌ MRSA nares swabs have excellent negative predictive value for MRSA pneumonia? They can be a great tool for dropping that empiric vancomycin! #ASPchat More: https://t.co/bXyJgvRn29 |
| Jamie Kisgen @KisgenUF RT @ASP_Chat: Q3 Follow-Up 3. Have you met π€ Dr. Plasma to help with empirical antimicrobial section? https://t.co/aeQjDUvnyx via @IDSAInfo 2018 from @julie_justo #ASPchat https://t.co/C3NcRCdMNx |
| Daniel MuΓ±oz, BCCCP @dfmunozp RT @FND_pharmacy: @ASP_Chat If I see voriconazole my eyes light up! Drug interaction city. One of the most potent ones with a commonly used med definitely voriconazole + midazolam. X4 increase in t1/2 and x3 AUC and Cmax increase ! #ASPChat https://t.co/CHKC5pUOB4 |
| Jamie Kisgen @KisgenUF This is such a great idea to help new ID learners see the big picture! Well done @julie_justo π#ASPchat |
 | Julio Cesar Zuniga @jczm1991 RT @WSPID: #nurses play a crucial role in healthcare services both in HIC and LMICs. A multidisciplinary approach in healthcare is key. Also multispeciality collaboration #PedsID #pediatricians #PedsICU |
 | Mojdeh Heavner @HeavnerPharmD RT @IDstewardship: @ASP_Chat A4. Meropenem will give you Listeria coverage so no need to add ampicillin to it for empiric π§ meningitis coverage. #ASPchat |
| Jamie Kisgen @KisgenUF RT @FuerteWilbert: One of the most powerful tools of a successful ASP and yet so underutilized... monthly collaborative meeting with prescribers within your institution #ASPchat https://t.co/hU2Tq5W5yM |
| Tony Gerlach @SICUPharmD RT @FuerteWilbert: One of the most powerful tools of a successful ASP and yet so underutilized... monthly collaborative meeting with prescribers within your institution #ASPchat https://t.co/hU2Tq5W5yM |
| Tony Gerlach @SICUPharmD RT @IDstewardship: @ASP_Chat A3. @BradSpellberg talked about how cidal isnβt that big of a deal many years ago at I think it was ICAAC. #ASPchat |
 | Joshua Torrance @JoshuaRTorrance @ASP_Chat Q2: Amoxi-clav doesn't get enough love. Reasonable pip-taz step down in many common infections with decent Gram positive and anaerobe coverage. Just remember to watch out for resistant organisms! #ASPChat |
| Wilbert J Fuerte PharmD, BCIDP @FuerteWilbert This is what happens when you collaborate with prescribers in your institution. They help YOU minimize quinolone use @IDstewardship #ASPchat https://t.co/cQk5Njef1K |
#ASPChat content from Twitter.